Experimental and Molecular Medicine (Oct 2020)

The impact of endotrophin on the progression of chronic liver disease

  • Min Kim,
  • Changhu Lee,
  • Dae Yun Seo,
  • Hyojung Lee,
  • Jay D. Horton,
  • Jiyoung Park,
  • Philipp E. Scherer

DOI
https://doi.org/10.1038/s12276-020-00520-8
Journal volume & issue
Vol. 52, no. 10
pp. 1766 – 1776

Abstract

Read online

Liver disease: Collagen fragment spurs liver inflammation and fibrosis Localized buildup in the liver of a collagen-derived cleavage fragment plays a critical role in accelerating the development of tissue scarring and liver cancer in mice. Using a transgenic mouse model of fatty liver disease, a team led by Philipp Scherer from the University of Texas Southwestern Medical Center, Dallas, USA, and Jiyoung Park of Ulsan National Institute of Science and Technology, South Korea, showed that liver-specific accumulation of a collagen fragment known as endotrophin leads to activation of inflammatory and fibrotic pathways. The mice subsequently develop metabolic dysfunction, insulin resistance and, with time, cancerous nodules in the liver. The findings suggest that endotrophin accumulation, when it occurs in liver tissue that already contains large depositions of fat, can overwhelm normal liver physiology and accelerate organ damage.